W
Wei Jiang
Researcher at Chinese Academy of Sciences
Publications - 541
Citations - 14554
Wei Jiang is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Micelle & Quantum dot. The author has an hindex of 53, co-authored 494 publications receiving 11455 citations. Previous affiliations of Wei Jiang include Paul Scherrer Institute & Sun Yat-sen University.
Papers
More filters
Journal ArticleDOI
Nano mixed particles enhanced Nickel-Cobalt composite coatings by scanning jet electrodeposition
Wei Jiang,Huigui Li,Yuanlong Chen,Cheng Wang,Liangcheng Sheng,Ya Chen,Lida Shen,Xiaoqing Huang,Yuanxia Lao +8 more
TL;DR: In this article , the nano-mixed particles (CeO2/Nip) were used as the reinforcing phase of Ni-Co alloy composite coating to improve the hardness and uniformity of composite coating.
Journal ArticleDOI
Do Government Subsidies Affect Analyst Forecast Accuracy?
Yiyuan Sun,Wei Jiang,Cheng Zeng +2 more
Journal ArticleDOI
The design of an “H” joystick for closed reduction and its application in segmental and comminuted femoral shaft fractures: an innovative technique
Zhaofeng Jia,Shijin Wang,Tinghui Xiao,Wei Jiang,Tianjian Zhou,Qisong Liu,Qisong Liu,Guangheng Li,Xinjia Hu +8 more
TL;DR: A joystick that can be used in the closed reduction of a fracture, which can correct lateral displacement and angulation, and has the advantage of multi-direction reduction is described.
Journal ArticleDOI
Remote sensing image quality assessment experiment with post-processing
TL;DR: Main conclusions include: image post-processing can improve image quality; image post -processing can improved image quality even with lossy compression, image quality with higher compression ratio improves less than lower ratio; and with the imagePost-processing method, imagequality is better, when camera MTF being within a small range.
Journal ArticleDOI
The efficacy of irinotecan supplementation for colorectal cancer: A meta-analysis of randomized controlled studies
TL;DR: Iinotecan as the adjunctive therapy to fluorouracil and leucovorin can increase the survival and objective response of patients with colorectal cancer, but the incidence of grade ≥3 adverse events is found to be increased after irinotecaan supplementation.